i-LIGHT N
₨ 4,200 – ₨ 11,500Price range: ₨ 4,200 through ₨ 11,500
- Light Cure, Bioinert, Radiopaque, Zirconia Based Nano-Hybrid Composite from i-Dental
- Available in 4 Gm Syringes and a Kit of 4 Syringes
- Made in EU
Light Cure, Bioinert, Radiopaque, Zirconia Based Nano-Hybrid Composite
Based on the Vita® shade System
Designed for a wide range of restorative applications, including anterior and posterior restorations.
The composite offers excellent polishability, shade stability, and mechanical properties, ensuring long-lasting aesthetic and functional restorations
Clinical Indications
For direct restorations of class I, II, III, IV and V cavities
For indirect restorations such as inlays, onlays
For Core Build Ups
Key Features
Reinforced with zirconium to achieve a balance of strength and aesthetics
Optimized filler composition with irregular particles for durability in high-stress areas
Smooth and homogeneous consistency allows easy application and effortless sculpting
Versatile use, suitable for direct and indirect restorations, including inlays, onlays, and cores
Long-lasting shade stability ensures consistent aesthetic results over time
Radiopaque formulation enhances X-ray visibility for post-procedural assessment
Safe and bioinert composition, compatible with enamel and dentin
Superior polishability enables a high-gloss, smooth surface finish
Physical Properties
Zirconium and silica / barium glass filler: main glass cluster size 0.25-1.5 µm
Inorganic filler loading by weight 77,63 %
Based on: UDMA Bis-GMA, EBPADMA TEGDMA
Flexural strength: 116.3 ± 3.8 MPa
Polymerization shrinkage 3.0 ± 0.46 %
Water solubility: 0.49 ± 0.02 μg/mm³
Water sorption: 18.05 ± 0.28 μg/mm³
Light curing time: 20 seconds
Depth of cure: 2.47 ± 0.03 mm
Shelf Life
4-Years from Manufacturing Date
Storage Instructions
Keep product tightly closed in dry well-ventilated place at 4-28°C
Protect from direct sunlight and heat sources.
Do not freeze
| Shades |
A1 Syringe ,A2 Syringe ,A3 Syringe ,Kit – 4 Syringes |
|---|

Reviews
There are no reviews yet.